The title compound, C7H7N3O2S, was prepared for comparison with diazox
ide, an antihypertensive agent, from a structural and pharmacological
point of view. The crystal structure determination shows that the 4H t
automeric (rather than the 2H) form is preferentially adopted by this
pyridothiadiazine derivative in the solid state.